Bernard Verrier is director of the joint unit CNRS-University of Lyon, LBTI, hosted at the Institute of Biology and Chemistry of Proteins (IBCP) in Lyon, France and he is director of a research team within the unit. Author of over 120 scientific publications and co-author of two patents related to this technology, Bernard is a scientific referent for Adjuvatis. He is at the origin of the concept of safe-by-design formulation based on particles.